Here, we detected a strong negative regulation of the TGF-β signaling pathway in tumor tissue after RNase A treatment, which was associated with the upregulation of Fam89b which is a TGF-β pathway suppressor (according to UniProt data, by sequence similarity). This evidence concerns the gene FAM89B and neoplasm.